Gilles Peytavin

19.3k total citations
267 papers, 6.3k citations indexed

About

Gilles Peytavin is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Gilles Peytavin has authored 267 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 225 papers in Infectious Diseases, 171 papers in Virology and 50 papers in Epidemiology. Recurrent topics in Gilles Peytavin's work include HIV/AIDS drug development and treatment (201 papers), HIV Research and Treatment (171 papers) and HIV/AIDS Research and Interventions (138 papers). Gilles Peytavin is often cited by papers focused on HIV/AIDS drug development and treatment (201 papers), HIV Research and Treatment (171 papers) and HIV/AIDS Research and Interventions (138 papers). Gilles Peytavin collaborates with scholars based in France, United States and Switzerland. Gilles Peytavin's co-authors include Christine Katlama, Anne‐Geneviève Marcelin, Vincent Cálvez, Roland Tubiana, Laurent Mandelbrot, Marc Wirden, Dominique Costagliola, Robert Farinotti, Françoise Brun‐Vézinet and Constance Delaugerre and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Gilles Peytavin

262 papers receiving 6.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gilles Peytavin France	40	4.8k	3.7k	1.2k	872	618	267	6.3k
Jan W. Mulder Netherlands	47	3.5k 0.7×	2.9k 0.8×	1.2k 0.9×	618 0.7×	479 0.8×	159	6.3k
Andrew Hill United Kingdom	43	4.8k 1.0×	3.1k 0.8×	1.8k 1.5×	1.2k 1.4×	993 1.6×	195	6.7k
Courtney V. Fletcher United States	48	5.5k 1.1×	4.2k 1.1×	2.1k 1.7×	1.3k 1.5×	489 0.8×	230	8.4k
Roy M. Gulick United States	50	8.3k 1.7×	6.7k 1.8×	1.9k 1.5×	1.6k 1.8×	526 0.9×	168	10.6k
Marta Boffito United Kingdom	37	3.4k 0.7×	2.0k 0.5×	1.0k 0.8×	1.1k 1.2×	229 0.4×	253	4.6k
Brian P. Kearney United States	40	3.9k 0.8×	2.4k 0.6×	1.1k 0.9×	843 1.0×	698 1.1×	93	5.1k
Veronica Miller United States	43	4.8k 1.0×	4.1k 1.1×	2.6k 2.2×	659 0.8×	855 1.4×	128	7.5k
Chloe Orkin United Kingdom	39	3.8k 0.8×	2.7k 0.7×	1.8k 1.5×	1.8k 2.1×	885 1.4×	168	6.0k
Richard M. W. Hoetelmans Netherlands	42	4.2k 0.9×	3.1k 0.8×	949 0.8×	768 0.9×	336 0.5×	139	5.2k
Graeme Moyle United Kingdom	44	4.9k 1.0×	3.8k 1.0×	1.5k 1.2×	2.4k 2.8×	458 0.7×	217	6.9k

Countries citing papers authored by Gilles Peytavin

Since Specialization

Citations

This map shows the geographic impact of Gilles Peytavin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilles Peytavin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilles Peytavin more than expected).

Fields of papers citing papers by Gilles Peytavin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilles Peytavin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilles Peytavin. The network helps show where Gilles Peytavin may publish in the future.

Co-authorship network of co-authors of Gilles Peytavin

This figure shows the co-authorship network connecting the top 25 collaborators of Gilles Peytavin. A scholar is included among the top collaborators of Gilles Peytavin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilles Peytavin. Gilles Peytavin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kably, Benjamin, Mathilde Briard, Claire Francoz, et al.. (2025). Population pharmacokinetics of aciclovir and its major metabolite 9-carboxymethoxymethylguanine and safety profile of valaciclovir in early liver transplant recipients. Journal of Antimicrobial Chemotherapy. 80(5). 1302–1308. 1 indexed citations

Seang, Sophie, Ève Todesco, M.A. Valantin, et al.. (2024). A case series of intermittent nucleoside analogue-based (NA) regimen to maintain HBV virological suppression in coinfected HBV/HIV patients with suppressed viremia. Infectious Diseases Now. 54(7). 104980–104980. 1 indexed citations

Bertine, Mélanie, Gilles Peytavin, Antoine Bachelard, et al.. (2024). Rapid Selection of HIV-2 Capsid Mutations in Salvage Therapy With Lenacapavir-containing Regimen. Clinical Infectious Diseases. 81(2). 341–344. 2 indexed citations

Ferré, Valentine Marie, Gilles Peytavin, Minh Lê, et al.. (2023). Pharmaco‐virological algorithm to target risk of drug resistance among a population of HIV‐infected key populations in Togo. Journal of Medical Virology. 95(2). e28535–e28535. 2 indexed citations

Lê, Minh, Quentin Le Hingrat, Pierre Jaquet, et al.. (2020). Removal of Remdesivir’s Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19. Antimicrobial Agents and Chemotherapy. 64(11). 16 indexed citations

Lê, Minh, Naïm Bouazza, Florence Gattacceca, et al.. (2020). Usefulness of therapeutic drug monitoring of rilpivirine and its relationship with virologic response and resistance in a cohort of naive and pretreated HIV‐infected patients. British Journal of Clinical Pharmacology. 86(12). 2404–2413. 9 indexed citations

Jaspard, Marie, Najoua El Helali, Dhiba Marigot-Outtandy, et al.. (2020). Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France. Emerging infectious diseases. 26(8). 1792–1800. 38 indexed citations

Lê, Minh, Pierre Jaquet, Juliette Patrier, et al.. (2020). Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients. Journal of Antimicrobial Chemotherapy. 75(9). 2657–2660. 11 indexed citations

Perrier, Marine, Charlotte Charpentier, Gilles Peytavin, et al.. (2017). Switch as maintenance to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate: week 48 results in a clinical cohort. Journal of Antimicrobial Chemotherapy. 72(6). 1745–1751. 7 indexed citations

10.

Seang, Sophie, Thuy Nguyen, Minh Lê, et al.. (2017). Darunavir/ritonavir monotherapy at a low dose (600/100 mg/day) in HIV-1-infected individuals with suppressed HIV viraemia. Journal of Antimicrobial Chemotherapy. 73(2). 490–493. 5 indexed citations

11.

Pourcher, Valérie, Aude Desnoyer, Lambert Assoumou, et al.. (2016). Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial. AIDS Research and Human Retroviruses. 33(1). 1–10. 24 indexed citations

12.

Descamps, Diane, Gilles Peytavin, Benoît Visseaux, et al.. (2015). Dolutegravir in HIV-2–Infected Patients With Resistant Virus to First-line Integrase Inhibitors From the French Named Patient Program. Clinical Infectious Diseases. 60(10). 1521–1527. 29 indexed citations

13.

Laouenan, Cédric, Patrick Marcellin, Martine Lapalus, et al.. (2014). Using Pharmacokinetic and Viral Kinetic Modeling To Estimate the Antiviral Effectiveness of Telaprevir, Boceprevir, and Pegylated Interferon during Triple Therapy in Treatment-Experienced Hepatitis C Virus-Infected Cirrhotic Patients. Antimicrobial Agents and Chemotherapy. 58(9). 5332–5341. 7 indexed citations

14.

Soulié, Cathia, Gilles Peytavin, Charlotte Charpentier, et al.. (2014). Antiretroviral-Experienced HIV-1-Infected Patients Treated with Maraviroc: Factors Associated with Virological Response. AIDS Research and Human Retroviruses. 31(5). 475–478. 4 indexed citations

15.

Loubet, Paul, Charlotte Charpentier, Benoît Visseaux, et al.. (2014). Short Communication: Prevalence of HIV-1 Transmitted Drug Resistance in Liberia. AIDS Research and Human Retroviruses. 30(9). 863–866. 8 indexed citations

16.

Todesco, Ève, Sophie Sayon, S. Fourati, et al.. (2013). Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies. Journal of Antimicrobial Chemotherapy. 68(12). 2882–2889. 3 indexed citations

17.

Caby, Fabienne, Catherine Blanc, Cathia Soulié, et al.. (2013). Efficacy of raltegravir switching strategies in HIV-infected patients with suppressed viraemia according to the genotypic sensitivity score. Infection. 42(2). 295–301. 1 indexed citations

18.

Gueye, Ndèye Fatou Ngom, Souleymane Mboup, Maouly Fall, et al.. (2010). Efficacy and Safety of Unboosted Atazanavir in Combination with Lamivudine and Didanosine in Naive HIV Type 1 Patients in Senegal. AIDS Research and Human Retroviruses. 26(5). 519–525. 1 indexed citations

19.

Canestri, Ana, Stéphane Jauréguiberry, Antoine Moulignier, et al.. (2010). Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy. Clinical Infectious Diseases. 50(5). 773–778. 294 indexed citations

20.

Danel, Christine, Raoul Moh, Gilles Peytavin, et al.. (2007). Short Communication: Lack of Indinavir-Associated Nephrological Complications in HIV-Infected Adults (Predominantly Women) with High Indinavir Plasma Concentration in Abidjan, Côte d'Ivoire. AIDS Research and Human Retroviruses. 23(1). 62–66. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact